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Abstract
Background: Cortical hyperexcitability due to abnormal fast-spiking inhibitory interneuron function has been
documented in fmr1 KO mice, a mouse model of the fragile X syndrome which is the most common single gene
cause of autism and intellectual disability.
Methods: We collected resting state dense-array electroencephalography data from 21 fragile X syndrome (FXS)
patients and 21 age-matched healthy participants.
Results: FXS patients exhibited greater gamma frequency band power, which was correlated with social and
sensory processing difficulties. Second, FXS patients showed increased spatial spreading of phase-synchronized high
frequency neural activity in the gamma band. Third, we observed increased negative theta-to-gamma but
decreased alpha-to-gamma band amplitude coupling, and the level of increased theta power was inversely related
to the level of resting gamma power in FXS.
Conclusions: Increased theta band power and coupling from frontal sources may represent a mechanism
providing compensatory inhibition of high-frequency gamma band activity, potentially contributing to the widely
varying level of neurophysiological and behavioral abnormalities and treatment response seen in full-mutation FXS
patients. These findings extend preclinical observations and provide new mechanistic insights into brain alterations
and their variability across FXS patients. Electrophysiological measures may provide useful translational biomarkers
for advancing drug development and individualizing treatments for neurodevelopmental disorders with associated
neuronal hyperexcitability.
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Background
Fragile X syndrome (FXS) is a neurodevelopmental disorder
resulting from silencing of the fragile X mental retardation
gene (FMR1) on the X chromosome, leading to reduced
production of Fragile X Mental Retardation Protein
(FMRP) [1] that causes atypical brain development and
function. Studies in fmr1 knockout (KO) mice have shown
enhanced activity of metabotropic glutamate receptors [2]
and reduced GABAergic transmission [3]. These alterations
are believed to cause an imbalance favoring excitation over
inhibition in brain neurophysiology [3–5].
Neurophysiological studies can clarify the functional
brain consequences of neurochemical and neuroanatomic
changes in FXS. fmr1 KO mice have abnormally high syn-
chrony of neocortical network activity and a threefold
higher neuronal firing rate during Up states [6, 7]. fmr1
KO mice have also shown increased EEG responses to
auditory stimuli via in vivo recordings [8–10]. Similarly,
enhanced auditory event-related potential (ERP) responses
(e.g. N1, P2) and reduced response habituation have been
reported in FXS patients [11–14].
Given the model of a neurophysiological imbalance lead-
ing to heightened neural excitability and the increased
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prevalence of seizures in FXS patients and fmr1 KO mice,
and with due consideration of the challenges integrating
knowledge from intracranial recordings and clinical data, it
is noteworthy that few EEG studies of resting brain func-
tion have yet been conducted with FXS patients. To our
knowledge there has only been one quantitative study of
resting state EEG in FXS presented in two reports [15, 16].
Excessive resting state theta and reduced alpha power in
FXS were reported, as well as decreased connectivity in
alpha and beta bands but increased connectivity in the
theta band. While informative, there were certain limita-
tions to that study. First, the sample size was small (8 FXS
patients). Second, the study investigated activity under
50 Hz, which excludes a significant component of the
gamma frequency band (30–80 Hz) [17–19]. This limita-
tion is important because gamma band power reflects the
level of high frequency spontaneous neural activity and is
of special interest for FXS in light of fmr1 KO mouse stud-
ies that have identified abnormalities in fast-spiking inhibi-
tory GABAergic interneurons [7, 20] which are critical
generators of gamma power in cell populations [21]. Third,
functional connectivity analysis was done using only 28
electrodes; a dense electrode montage can better capture
the full pattern of functional connectivity across the neo-
cortex. Fourth, the study was insufficiently powered to
identify correlations between resting state oscillatory abnor-
malities in FXS and measures of clinical symptom severity.
Alpha rhythms are the most dominant oscillation during
the resting state and play an inhibitory role in information
processing systems [22]. Theta rhythms also reflect top-
down inhibitory and organizational influences especially
during higher cognitive activity [23], and altered theta-
gamma coupling has been linked with cognitive dysfunc-
tion in fmr1 KO mice [24]. As increased gamma activity is
believed to be linked to increased neural excitability,
examining the relationship of alpha and theta band activ-
ity with gamma band activity might provide mechanistic
system-level understanding about the altered balance be-
tween excitatory and inhibitory activity.
The aim of the present study was to investigate resting
state EEG activity in FXS patients focusing on resting
EEG power—specifically gamma band power, functional
connectivity, and gamma coupling. We hypothesized
that resting state EEG power in FXS would be enhanced
in both low- and high-frequency bands (theta and
gamma) but reduced in middle range frequencies (alpha)
relative to healthy controls. Second, we predicted that
functional connectivity in FXS would be reduced in
long-range connections but increased in short-range
connections dominated by gamma band oscillations rela-
tive to controls. Third, we predicted that FXS patients
would show reduced alpha-to-gamma coupling consist-
ent with reduced top-down alpha-related inhibition on
local cortical excitability in sensory systems. Fourth, we
hypothesized that altered resting EEG power spectra in




Twenty-one FXS participants with a full mutation (greater
than 200 CGG repeats) (six females, 15 males, mean age =
25.6 years, SD = 11.1, range 12–57) and 21 healthy age-
matched controls (six females, 15 males, mean age =
26.4 years, SD = 10.5, range 10–55) participated in this
study (Table 1). None had a history of nonfebrile seizures
or treatment with anticonvulsant medication. Healthy con-
trols had no known prior diagnosis or treatment for a psy-
chiatric or neurological illness or history of developmental
delay in educational achievement. FXS participants taking
psychiatric medications were receiving a stable dose for at
least 4 weeks prior to participation. Nine FXS participants
were receiving one or more psychiatric medications: 5 on
antipsychotics, 5 on antidepressants, and 2 on psychosti-
mulants. Treated patients did not differ on reported EEG
measures (see Additional file 1: Table S1). Primary analyses
were done with the whole sample, with confirmatory ana-
lyses done with the male participants.
The Adolescent and Adult Sensory Profile [25] and the
Social Communication Questionnaire (SCQ) [26] were
completed for FXS participants by their primary caregiver
or close family member. IQ of FXS participants was
Table 1 Demographic, intellectual, and clinical characteristics of study participants
FXS n = 21 Healthy controls n = 21
Mean Std dev Range Mean Std dev Range t statistic (df)
Age 25.6 11.1 12–57 Age 26.4 10.5 10–55 0.24 (40) p = 0.809
Full scale IQ 55.1 14.8 47–94 Full scale IQ 106.3 10.7 82–123 12.8 (40) p < 0.001
Verbal 2.9 3.2 1–11 Verbal 107.7 11.7 82–124
Nonverbal 2.0 1.9 1–7 Performance 103.2 11.8 82–125
SCQ scores 17.7 8.6 2–31
Sensory Profile 31.6 4.7 24–40
IQ assessed by Stanford Binet in FXS and estimated using the Wechsler Adult Scale of Intelligence in healthy controls
SCQ Social and Communication Questionnaire
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assessed using the Stanford-Binet Intelligence Scale 5th
Ed. [27] which characterizes intellectual ability across a
broad ability and age range. IQ of healthy controls was es-
timated using the briefer Wechsler Abbreviated Scale of
Intelligence (WASI) [28] (Table 1). The project was ap-
proved by the University of Texas Southwestern Institu-
tional Review Board, and informed consent was obtained
from all participants, except when appropriate from a par-
ent with participant assent.
EEG recordings and preprocessing
Five minutes of continuous EEG data was collected. Par-
ticipants were comfortably seated while watching a silent
video (cartoon movie, standardized across participants),
done to facilitate cooperation in the FXS patients as in
previous studies [29]. EEG data were recorded with a
128-electrode Biosemi Active Two system at a sampling
rate of 512 Hz. Two additional electrodes, positioned
near to the electrode POz of the international 10-20 sys-
tem [30], served as recording reference [common mode
sense (CMS) active electrode] and ground. The initial
10 s of recordings were excluded from processing to
minimize movement artifacts. Raw EEG data were fil-
tered and transformed to an average reference using the
EEGLAB toolbox [31]. High- and low-pass cutoff fre-
quencies were set at 0.5 and 100 Hz; a 60-Hz notch filter
was used for removal of power-line noise. Then, EEG
data were subjected to Fully Automated Statistical
Thresholding for segmentation with 2 s each and EEG
Artifact Rejection (FASTER) [32], and artifacts including
eye blink, muscle activity, and cardiac activity were re-
moved. This process included 5 steps: (1) outlier chan-
nels were identified and replaced with interpolated
values in continuous data; (2) continuous data was seg-
mented into 2-s epochs; (3) outlier epochs were removed
from participants’ epoch set; (4) spatial independent
components analysis was applied to remaining epochs,
outlier components were identified (including compo-
nents that correlated with EOG activity), and data were
backprojected without these components; and (5) within
an epoch, outlier channels were interpolated.
EEG power
There was no significant group difference in the number
of artifact-free epochs (Epochscontrol = 138, SD = 5.8;
EpochsFXS = 139, SD = 4.7, p > 0.05) or number of interpo-
lated channels (Interplolated_channelcontrol = 2.33, SD =
1.2; Interplolated_channelFXS = 2.81, SD = 2.06, p > 0.05).
For each channel, every 2-s epoch was detrended, tapered
with a Hanning window, and transformed in Matlab using
a Fourier (FFT) algorithm, yielding Fourier coefficients in
0.5 Hz frequency steps. The Fourier coefficients were then
squared to yield power values (uV2). To be comparable
with previous resting-state EEG reports on FXS [16], we
divided our frequencies into six frequency bands of inter-
est as follows: delta (1–3 Hz), theta (4–7 Hz), lower alpha
(8–10 Hz), upper alpha (10–12 Hz), beta (13–30 Hz), and
gamma (30–80 Hz). Alpha band activity was separated
into higher and lower bands because previous studies
showed that higher alpha is state dependent and sensitive
to arousal while lower alpha is not [33], as well as to per-
mit direct comparison with the previous resting EEG
study of FXS [15, 16]. To minimize effects of inter-
individual variability in total power, relative power was
obtained by computing the fraction of power in each fre-
quency band divided by the sum of power measurements
across 1–80 Hz for each frequency band in each of the
128 channels. Group comparisons in relative power
(power at specific frequency/total power) between healthy
and FXS individuals were performed at every channel. To
correct for multiple comparisons and identify significant
clusters among channels with group differences in a fre-
quency band, a cluster-based permutation test in the Mass
Univariate ERP Toolbox was used for statistical compari-
sons (5000 permutations [34]).
Connectivity analysis
Functional connectivity among all electrode pairs was
examined separately in each of the six frequency bands
of interest using the debiased weighted phase lag index
(dbWPLI) [35]. This method minimizes artifacts result-
ing from spurious inflation of scalp EEG connectivity
caused by volume conduction. The dbWPLI calculates
an unbiased index of phase synchronization between
two time series, weighted by the magnitude of the im-
aginary component of the cross-spectrum. Compared to
a direct phase lag index (PLI), the dbWPLI has mini-
mum sample-size bias and improved ability to detect
phase synchronization patterns. The dbWPLI value
ranges from 0 to 1, with zero indicating the absence of
phase-lagged coupling and one indicating the strongest
possible coupling.
EEG data were imported to FieldTrip (Donders Institute
for Brain, Cognition and Behaviour, Radboud University,
Nijmegen, The Netherlands: http://www.ru.nl/neuroimag-
ing/fieldtrip/) for calculating dbWPLI among all electrode
pairs (8128 pairs) at each of the six frequency bands of
interest. Then, at each frequency band, the obtained
dbWPLI difference between FXS and control groups at
each electrode pair was tested using a permutation ap-
proach [36]. At each electrode pair, dbWPLI from the 21
FXS and 21 control participants were shuffled and ran-
domly separated into two groups in order to calculate the
difference in group-mean dbWPLI for each permutation.
This was repeated 5000 times, providing a distribution of
dbWPLI values for each electrode pair for comparison
with actual group differences, which were considered sta-
tistically significant if they exceeded the 95% confidence
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interval of the distribution of dbWPLI differences at the
corresponding electrode pair (two-tailed test). A false dis-
covery rate (FDR) approach was implemented in EEGLAB
[31] to control the Type I error rate given the multiple
comparisons.
We then evaluated the channel pair distribution for each
frequency band showing group differences (Fig. 1) by calcu-
lating Euclidean distances between channel pairs based on
the 3D position coordinates of electrodes for BioSemi head-
caps (Biosemi Instrumentations, Amsterdam, Netherlands),
with distances normalized (maximum distance was set to
1). This was done to determine if there was a pattern of
altered connectivity between groups specific to short- or
long-range connections.
Cross-frequency amplitude coupling
To investigate potential associations of alpha and theta ac-
tivity with gamma activity, we evaluated cross-frequency
amplitude coupling over time. Cross-frequency coupling re-
fers to dependence between electrophysiological activities in
different frequency bands [37]. Time series in each electrode
were segmented into 2-s epochs. Relative lower and upper
alpha, theta, and gamma power were calculated for each
epoch. After that, two kinds of correlations were computed
between the epoch-by-epoch gamma power with alpha
(lower and upper) and theta power [38]. First, correlations
were computed in data from every electrode to investigate
the local interaction among frequency bands, which we
referred as “local coupling” (Additional file 2: Figure S1).
Second, correlations were computed between mean power
of electrode clusters at the anterior locus showing max-
imum relative theta power and at the posterior locus show-
ing maximum relative alpha power based on topographies
of EEG power (Fig. 2) with gamma power in all other
electrodes, which we refer to as “global coupling”. This was
done to investigate the association of gamma power in an
electrode with activity in alpha and theta bands in other
electrodes, the latter both being believed to exert inhibitory
modulation over distant brain regions [22]. To correct for
multiple comparisons and evaluate differences between
control and FXS groups, the correlation coefficients in each
electrode and for each subject were transformed to Z scores
via Fisher’s Z-transform and then evaluated with a cluster-
based permutation test in the Mass Univariate ERP Toolbox
for statistical comparisons (5000 permutations [34]).
For correlations showing significant differences between
controls and FXS patients (Fig. 3a, Additional file 2: Figure
S1A), we also tested whether they were significantly
Fig. 1 a Significant group differences in connectivity strength between FXS and healthy control participants based on permutation tests (p < 0.05)
show increased connectivity in FXS in the gamma band across electrodes but reduced within-band connectivity in the alpha (lower and upper) and
beta range. b Mean and standard error of between-electrode distances for electrode pairs showing group differences (plotted in a) in lower alpha,
upper alpha, beta and gamma bands. Asterisk denotes significant differences in connectivity distances with significant group differences between
bands at p < 0.05. c Bivariate scatter plots depicting the relationship between average connectivity strength (dbWPLI) and average between-electrode
distance for FXS (red dots) and healthy control participants (black dots)
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different from zero using a non-parametric permutation
approach. To obtain a null distribution for these explora-
tory correlational analyses, epoch order of gamma power
was shuffled while keeping the same epoch order for alpha
and theta power. Correlations between alpha and gamma
and between theta and gamma were computed for each
permutation and repeated 2000 times providing a distri-
bution of correlation values. The correlation for each sub-
ject was considered statistically significant if it was beyond
the 95th percentile of this distribution.
Fig. 2 Scalp topographies of relative power spectrum for FXS and healthy control participants per frequency band, with significant group
differences presented in the bottom row (p < 0.05, corrected). Relative power represents the percentage of power in each frequency band
divided by total power across 1–80 Hz
Fig. 3 a Scalp topographies of “global coupling” showing correlations between activity in the region showing the maximum relative power of
activity in the theta, and lower and upper alpha power bands defined as the average of the power in that region of electrodes clusters (marked
with *) and gamma power in all other electrodes for FXS and healthy control participants. Significant group differences are presented in the
bottom row (p < 0.05, corrected), with dark blue reflecting no group difference. b Mean and standard error of correlations for all electrodes
showing group differences as are plotted in A. Asterisk denotes correlations of spectral power in theta and upper alpha bands with gamma band
power that are significantly different from zero based on the results of permutation analyses at p < 0.05
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Results
EEG power
Cluster-permutation testing showed stronger relative activ-
ity in FXS compared to controls in the theta and gamma
frequency bands, with clusters of significant group differ-
ences seen in the frontal and occipital regions (Fig. 2). In
addition, two way anova (group X frequency [30-80Hz])
showed no interaction between group and frequency. So
the magnitude of group differences did not vary across the
gamma band (30-80Hz). FXS patients also showed reduced
lower alpha band activity than controls in frontal and oc-
cipital regions, while reduced upper alpha activity was
widely distributed (cluster covering most electrodes). There
were no differences between FXS and control participants
in delta or beta frequency band power.
Functional connectivity
The pattern of resting state functional connectivity results
is illustrated in Fig. 1. The FXS group showed reduced con-
nectivity in lower alpha, upper alpha, and beta frequency
bands, but increased connectivity in the gamma frequency
band (Fig. 1a). There were no group differences in within
frequency band connectivity for delta or theta band activity.
Paired t tests (Fig. 1b) showed that distances between
electrode pairs with significant group differences in phase
synchronized connectivity were significantly shorter in the
gamma band where connectivity was increased in FXS than
in lower alpha, upper alpha, and beta bands where connect-
ivity in FXS was reduced. In each frequency band, a linear
regression was computed with degree of connectivity as the
dependent variable and with between-electrode distance,
group (FXS, Controls), and their interaction as independent
variables (Fig. 1c). Results indicated no significant effects in
the lower alpha band. In the upper alpha band, there was a
significant interaction between group and electrode distance
(t = 3.0, p = 0.003). Upper alpha connectivity in controls de-
creased with increased electrode distance (t = 3.6, p < 0.001);
this effect was not seen in FXS. In the beta band, both
between-electrode distance (t = 12.0, p < 0.001) and its inter-
action with group (t = 3.8, p < 0.001) were significant.
Although both groups showed decreased beta connectivity
with increased between-electrode distance, the effect was
significantly reduced in FXS patients. In the gamma band,
both between-electrode distance (t = 7.9, p < 0.001) and its
interaction with group (t = 9.9, p < 0.001) were highly signifi-
cant. Although both groups showed decreased gamma con-
nectivity with greater between-electrode distance, the FXS
group showed stronger effects. Because connectivity at a
scale on the order of even short electrode distances is well
beyond the scale maintained by individual PV positive in-
hibitory neurons, the observation of increased functional
connectivity of gamma band activity in FXS across a variety
of inter-electrode distances indicates a greater spread of
coherent high frequency neural activity in FXS than in
controls.
Cross-frequency amplitude coupling
When evaluating amplitude coupling across electrodes,
cluster-permutation testing showed that the inverse correl-
ation between upper alpha and gamma power was signifi-
cantly reduced in FXS patients compared to controls in the
occipital, parietal, and frontal regions (Fig. 3a). There were
no lower alpha to gamma power correlation differences be-
tween FXS and controls. The opposite pattern was seen in
the theta band, where negative theta to gamma power cor-
relations were stronger in FXS compared to controls, with
clusters of significant group differences in cross-frequency
coupling seen in the occipital, parietal, and frontal regions.
Follow-up permutation tests showed that negative theta to
gamma power correlation was significantly greater than
zero only in FXS participants, while the negative upper
alpha to gamma power correlation was significant only in
controls (Fig. 3b). For amplitude coupling within individual
electrodes, performed to examine local circuitry effects,
cluster-permutation testing showed a similar pattern with
stronger negative theta to gamma power correlation, but re-
duced upper alpha to gamma power correlation in FXS
compared to controls (Additional file 2: Figure S1 and
Additional file 3: Figure S2).
These results suggest that while upper alpha power nega-
tively coupled with gamma power both within and across
electrodes in controls, FXS patients displayed excessive
gamma activity and reduced upper alpha power without
showing a coupling of gamma and upper alpha band activ-
ity. In other words, reduced upper alpha-related inhibition
of gamma power was observed in FXS. Instead, FXS
showed stronger negative theta to gamma power coupling
both within and across electrodes. Follow-up phase ampli-
tude coupling analyses were not significant (see Additional
file 4).
Severity of gamma abnormalities in FXS patients
In order to characterize the prevalence of the different
abnormalities we observed, we computed individual par-
ticipant values for each parameter showing significant
abnormalities in FXS patients, including alterations in
gamma activity in power, functional connectivity, and
cross-frequency amplitude coupling (Fig. 4). FXS partici-
pants showed variable levels of increased gamma power,
with somewhat greater group separation in gamma con-
nectivity indices. Amplitude coupling measurements
more robustly and consistently separated FXS and
healthy study participants. For example, while only ap-
proximately 50% of FXS patients had gamma power
levels increased more than 1 SD beyond healthy controls,
almost every FXS participant had altered long distance
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coupling (outside the range of normal values) of local
gamma with local and global upper alpha and theta activ-
ity. The heterogeneity in gamma power is noteworthy
since all FXS participants had documented full muta-
tions. The findings of altered long distance functional
connectivity suggest that different patterns of cortico-
cortical connectivity may be an important factor contrib-
uting to neural hyperexcitability reflected in increased
gamma power in FXS.
Correlations with demographic and clinical variables
Exploratory correlational analyses were performed be-
tween EEG measurements showing significant alteration
in FXS and SCQ and Adolescent/Adult Sensory Profile
scores in FXS participants. Increased resting gamma
power was significantly correlated with social-
communication abnormalities as assessed with the SCQ
(r = 0.56, p = 0.03). Lower alpha power was significantly
correlated with greater social impairment in SCQ scores
(r = −0.58, p = 0.02) and with hypersensitivity to sensory
stimuli on the Sensory Profile scale (r = −0.51, p = 0.03).
For functional connectivity and cross-frequency coup-
ling measurements, no correlations with clinical vari-
ables were significant. Within each group, no significant
correlations for EEG parameters were observed with age
or gender. The consistent and marked reductions in IQ,
especially in male FXS patients (all with IQ between 40
and 50), made correlations with electrophysiological pa-
rameters difficult to meaningfully evaluate.
Sex differences in FXS
The FXS full mutation in males is typically associated with
a more severe profile of intellectual and behavioral deficits
due to females having a compensatory functional FMR1
gene on their typically unaffected X chromosome. There-
fore, it is important to consider gender effects in our
analyses. We repeated all of the above analyses in two ways.
First, we analyzed the male only group and all reported ef-
fects remained significant (see Additional file 5: Figure S3,
Additional file 6: Figure S4, Additional file 7: Figure S5, and
Additional file 8: Figure S6). Second, we compared male
and female participants and did not find significant sex dif-
ferences (see Additional file 9: Figure S7, though power to
detect such effects was not high).
Discussion
This case-control study investigated multiple aspects of
brain system function in the largest sample of non-
epileptic, full mutation FXS patients studied to date with
quantitative dense-array resting-state EEG. Abnormal-
ities were evident across measures of spectral power,
functional connectivity, and cross-frequency amplitude
coupling and were consistent with predictions based on
the fmr1 KO mouse electrophysiology [7, 20, 24]. First,
alterations in gamma band activity involved increased
Fig. 4 Scatter plot of each participant’s values on three gamma measurements for FXS and healthy control participants: a gamma power, b
gamma connectivity, and c amplitude coupling of gamma with theta and alpha band activity across electrodes. Circle denotes female
participants, and plus sign denotes male participants
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relative gamma power and an increased coherence of
gamma band activity across nearby electrodes. This pat-
tern is consistent with an imbalance of excitatory over
inhibitory activity in FXS. The associations of electro-
physiological alterations with abnormalities in social
function and sensory sensitivities provide the first evi-
dence of the clinical relevance of quantitative EEG find-
ings in this population. Secondly, relative to controls,
individuals with FXS showed reduced gamma amplitude
coupling with upper alpha band activity but increased
coupling with theta activity. As alpha and theta band ac-
tivity are believed to exert top down inhibitory and regu-
latory modulation of sensory systems, these observations
provide novel evidence that hyperexcitability in sensory
cortex involves not only altered local circuit dysfunction
in the interaction of interneurons and pyramidal cells as
demonstrated in the fmr1 KO mouse [7], but also alter-
ations in the long distance functional connectivity from
association cortex and thalamus to sensory cortex
known to regulate local circuit excitability. While there
was better group separation on the amplitude coupling
indices, clinical correlations were significant only with
the power of resting gamma alterations. This pattern of
findings suggests that variable disease-related disturbances
and compensatory adaptations may leave FXS patients
with a net level of residual neural hyperexcitability
reflected in elevated gamma power that determines im-
portant aspects of their level of neurological and func-
tional disability. These findings provide new mechanistic
understanding of cortical hyperexcitability in FXS, involv-
ing increased high-frequency local circuit activity that var-
ied in relation to what appear to be abnormal and
compensatory long-distance functional connectivity. They
also suggest a potential utility of resting state EEG alter-
ations as translational biomarkers for clinically relevant
aspects of FXS biology for identifying individual FXS pa-
tients likely to benefit from treatments aimed at reducing
neocortical hyperexcitability and for tracking those effects.
The U-shaped pattern of relative EEG power in indi-
viduals with FXS (Fig. 2) is similar in form to one we de-
scribed previously in autism [39]. Compared to healthy
age-matched control participants, FXS patients showed
enhanced power in lower (theta) and higher (gamma)
bands, but reduced power in intermediate low and high
alpha bands. Elevated theta and reduced alpha power
have been reported previously in FXS [15], but the en-
hanced power in the gamma band and its clinical rele-
vance have not been previously described. This
enhanced gamma power is consistent with studies of
fmr1 knockout mice demonstrating heightened neuronal
excitability related to alterations in input to fast-spiking
inhibitory interneurons that synchronize and control
high-frequency gamma band neural activity [4, 40]. A re-
cent study in wild-type rats showed that enhanced
gamma oscillation was observed when NMDA-receptor
blockade was established [41]. NMDA-receptor hypo-
function has been reported in several studies with fmr1
knockout mice [42–44] and thus may be one contribut-
ing factor for the gamma band alterations observed in
the present study.
Our functional connectivity analyses revealed reduced
long-range functional connectivity in the alpha and beta
bands, but enhanced shorter-range connectivity in the
gamma band in FXS. The decreased functional connect-
ivity in the alpha and beta bands parallels previous find-
ings in FXS [16]. We did not however observe the
increased connectivity within the theta band that has
been reported, though we did observe increased theta
gamma coupling. For the first time, we report increased
connectivity in gamma band activity in FXS patients. A
previous fmr1 KO mouse study examined cross-
frequency theta-gamma coupling, but during a cognitive
task and when computed in the same hippocampal elec-
trode [24]. While related to focus of the present study,
the differences in species, in rest vs task performance sit-
uations, and within rather than across distant brain sites
are differences that future work will need to resolve to
integrate the observations. Further translational work
bridging preclinical and clinical findings is needed to
more directly link clinical neurophysiological findings to
observations seen in fmr1 KO mice.
Our observation of increased spatial extent of coherent
gamma band activity across more distant electrode pairs
suggests an increased cortical spread of neural excitabil-
ity paralleling effects observed in slice preparation data
but on a far greater spatial scale [7]. It aligns with obser-
vations of increased neural synchrony observed in fmr1
knockout mice during sleep and quiet wakefulness [6].
The pattern of reduced long range connectivity in the
alpha and beta bands suggests that reduced top-down
inhibitory regulation of neocortical sensory systems may
contribute to increased neural excitability of sensory cor-
tex in FXS.
Given the alterations we observed in EEG power and
functional connectivity in FXS, we investigated the
coupling between low frequency band activity that was
abnormal (alpha and theta activity) and high-frequency
gamma band activity both within and across electrodes.
We did this to determine whether the pattern of findings
seen in gamma power and connectivity was related to a
disruption in top-down modulation. Based on EEG data,
it is not possible to determine whether a local circuit
dysfunction is causing or resulting from the altered pat-
tern of reduced long-distance functional connectivity in
FXS. However, previous studies have shown that low
frequency oscillations (e.g., alpha, theta) provide top-
down inhibitory and modulatory influences in large, dis-
tributed neural networks, whereas fast oscillations (e.g.,
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gamma) at rest are more related to neurophysiological
tone in local networks [45]. Thus, the reduced alpha
power, connectivity, and amplitude coupling in FXS may
represent a failure of top-down modulation provided by
alpha band input that could reduce gamma power in
sensory systems. Previous studies have characterized the
functional role of alpha band activity as actively inhibit-
ing the processing of sensory information at rest and
when environmental cues are not task relevant [22]. Pos-
terior alpha has been reported to provide top-down con-
trol especially in visual attention studies, and thalamus
has been identified as an important source of cortical
alpha oscillations [46]. Both simulation and experimental
studies have demonstrated that lower frequency oscilla-
tion rhythms (e.g., alpha, theta) can sustain long-range
synchronization [45, 47], while synchronous activity in
higher oscillation rhythms (e.g., gamma) declines more
rapidly with increasing distances [48]. As a result, slower
oscillations are better suited for top-down modulation
by synchronizing and organizing activity across different
brain regions [45]. This is consistent with findings from
a nonhuman primate study of V1 and V4 showing that
gamma rhythms propagate in a feedforward fashion
from early to higher level visual processing regions,
whereas alpha rhythms propagate in a feedback fashion
to primary visual cortex [49].
In contrast to the reduced upper alpha-to-gamma
coupling, FXS showed strong theta-to-gamma coupling
with atypical theta connectivity being related to lower
levels of gamma power (Fig. 3). Thus, while alpha
power and coupling were reduced, theta power and
coupling were increased in FXS, indicating a fundamen-
tal alteration in the pattern of cortico-cortical connect-
ivity that supports top-down modulation in sensory
systems. Further clinical and preclinical studies are
needed to fully clarify the meaning of this novel obser-
vation, but one possibility is that in the context of re-
duced inhibitory modulation of alpha oscillations on
gamma band activity, a second long-distance regulatory
circuitry operating in the theta band may be relied
upon to downregulate high-frequency neural activity in
the gamma band, a compensation which is only par-
tially and variably successful given the observation of
clinically relevant increased gamma power in FXS. As
theta power phasically synchronizes neural activity
across brain regions to support different types of higher
level cognition [50], a tonic activation to suppress sen-
sory hyperexcitability reflected in increased theta power
at rest might limit that phasic modulation and thereby
contribute to the severe intellectual limitations often
seen in FXS. Reduced alpha power might also contrib-
ute to the severe intellectual limitation since alpha
activity has been reported to positively correlate with
cognitive parameters [51].
The functional role of theta oscillation is related to its
neural sources in the prefrontal and anterior cingulate
cortex (ACC) [52], which play important roles in inhibi-
tory control of behavior, behavioral flexibility, and error
monitoring [53, 54]. During tasks requiring top-down
inhibition of attention or behavior, microelectrode re-
cordings in superficial cingulate layers exhibit strong
task-related theta activity [55]. In addition, intermittent
theta-burst stimulation has been shown to increase cor-
tical inhibition in rat neocortex by reducing parvalbumin
expression in fast-spiking interneurons [56], and stimu-
lation in theta frequency bands increases expression of
GABA precursors in inhibitory cortical systems [57].
Our gamma amplitude coupling associations may repre-
sent neural system factors that in vivo impact local cir-
cuit neurophysiology known to be altered in FXS, such
as alterations in metabotropic glutamate receptor
(mGluR) activation believed to be a cause of neuronal
hyperexcitability in FXS. Inhibitory interneurons in
mouse neocortex have been reported to fire in the theta
frequency during mGluR activation [44, 58]. In addition,
FMRP is highly expressed in the hippocampus [59], and
long-term potentiation (LTP) elicited by theta burst
stimulation has been reported to be impaired in the
CA1 hippocampal subfield in fmr1 KO mice [60].
Interest in systems biology alterations to complement
understanding of local circuit pathology may be import-
ant not only for comprehensive models of pathology in
FXS, but because individual variability in system-level
modulatory factors may contribute to the wide range of
clinical phenotypes seen even in patients with full muta-
tion. This variability might explain the inconsistent treat-
ment response to drugs targeting mGluR and other
mechanisms aiming to reduce neuronal hyperexcitability,
which have had more consistently positive effects in ani-
mal models. In this context, our findings not only pro-
vide new mechanistic understanding of FXS but also
suggest that EEG studies of FXS may provide biomarkers
for delineating disease heterogeneity and predicting and
tracking response in human and mouse models to drugs
targeting neuronal hyperactivity. Such approaches are
urgently needed to advance drug development and per-
sonalized medicine for FXS patients. Our observation
that quantitative EEG alterations were related to the se-
verity of social communication and sensory reactivity
problems supports the potential clinical utility of this
approach.
This study has certain limitations, including the wide age
range (12–57 years old) and the fact that younger children
were not assessed. Although FXS and control groups were
age-matched and no significant age effects were observed
in the data, studies with younger populations remain an im-
portant target for future research. Other effects such as sex
differences and medication effects were not statistically
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significant, but further research is needed to address those
issues. Third, our study did not compare resting state ab-
normalities in FXS directly with other developmental dis-
abilities to establish specificity of deficits to FXS relative to
general effects of intellectual or developmental disability.
While the parallel findings from our study and preclinical
work in fmr1 KO mice suggest a relevance to FXS, more re-
search is needed to determine whether similar findings
might be seen in the subset of ASD patients who demon-
strate sensory hypersensitivities or other signs of cortical
excitability, as well as in multiple other neurodevelopmental
disorders.
Conclusions
In summary, we found an abnormal U-shaped alteration
of spectral power with reduced long-range inhibitory
and enhanced excitatory shorter-range connectivity in
FXS. Furthermore, we found stronger theta-to-gamma
amplitude coupling in FXS, possibly serving as a com-
pensatory response to reduced top-down alpha-band in-
hibitory modulation and intrinsic pathology of local
neural circuit excitability in sensory systems. Taken in
combination, our findings provide direct in vivo evi-
dence in FXS patients of heightened cortical arousal, re-
duced top-down regulatory input in the alpha band, and
increased modulation in the theta band that together
may determine the level of circuit hyper-excitability in
sensory cortex in vivo.
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